Related Experiment Video
Updated: Oct 31, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Promyelocytic leukemia protein: an atherosclerosis suppressor protein?
Cali B Corbett1, Amanda K St Paul1, Michael V Autieri1
1Independence Blue Cross Cardiovascular Research Center Lemole Center for Integrated Lymphatic Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, U.S.A.
Abstract:
As many as 70% of cells in atherosclerotic plaque are vascular smooth muscle cell (VSMC) in origin, and pathways and proteins which regulate VSMC migration, proliferation, and phenotype modulation represent novel targets for rational drug design to reduce atherosclerotic vascular disease. In this volume of Clinical Science, Karle et al. demonstrate that tumor suppressor, promyelocytic leukemia protein (PML) plays an important role in regulation of VSMC phenotype and response to inflammatory stimuli (Clin Sci (2021) 135(7), 887-905; DOI: 10.1042/CS20201399). This important work demonstrates that PML, previously unrecognized as a participant in development of atherosclerosis, may represent a novel target for anti-atherosclerotic therapeutic modalities.
Insights
Vascular smooth muscle cells (VSMCs) are key in atherosclerosis. Research shows the tumor suppressor, promyelocytic leukemia protein (PML), regulates VSMC phenotype and inflammatory response, offering a new therapeutic target for this disease.
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
- Atherosclerosis Research
Background:
- Vascular smooth muscle cells (VSMCs) constitute up to 70% of atherosclerotic plaque.
- VSMC migration, proliferation, and phenotype modulation are critical in atherosclerotic vascular disease development.
- Novel therapeutic targets are needed to manage atherosclerosis.
Purpose of the Study:
- To investigate the role of the tumor suppressor, promyelocytic leukemia protein (PML), in regulating VSMC phenotype.
- To determine PML's involvement in VSMC response to inflammatory stimuli.
- To explore PML as a potential therapeutic target for atherosclerosis.
Main Methods:
- The study by Karle et al. examined the function of PML in VSMC.
- Investigated the impact of PML on VSMC phenotype modulation.
- Assessed VSMC responses to inflammatory stimuli in the context of PML expression.
Main Results:
- PML plays a significant role in regulating VSMC phenotype.
- PML influences VSMC response to inflammatory stimuli.
- PML was previously unrecognized in atherosclerosis development.
Conclusions:
- PML is an important regulator of VSMC phenotype and inflammatory response.
- PML represents a novel therapeutic target for anti-atherosclerotic drug design.
- Targeting PML may offer new strategies to combat atherosclerotic vascular disease.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Abnormal Proliferation
Peripheral Artery Disease I: Introduction

